Skip to main content
Article
Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
Clinical Epigenetics
  • Katherine A Sanders, Bond University
  • Miles C Benton, Genomics Research Centre, Brisbane
  • Rod A Lea, Genomics Research Centre, Brisbane
  • Vicki E Maltby, Hunter Medical Research Institute, Newcastle
  • Susan Agland, John Hunter Hospital
  • Nathan Griffin, Hunter Medical Research Institute, Newcastle
  • Rodney J Scott, University of Newcastle
  • Lotti Tajouri, Bond University
  • Jeannette Lechner-Scott, University of Newcastle
Date of this Version
8-27-2016
Document Type
Journal Article
Publication Details

Published version

Sanders, K.A., Benton, M.C., Lea, R.A., Maltby, V.E., Agland, S., Griffin, N., Scott, R.J., Tajouri, L., Lechner-Scott, J. (2016). Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells. Clinical Epigenetics, 8(87), 1-8.

Access the journal

© 2016 The Author(s)

Distribution License
Creative Commons Attribution 4.0
Abstract
BACKGROUND: Immunoactivation is less evident in secondary progressive MS (SPMS) compared to relapsing-remitting disease. MicroRNA (miRNA) expression is integral to the regulation of gene expression; determining their impact on immune-related cell functions, especially CD4+ T cells, during disease progression will advance our understanding of MS pathophysiology. This study aimed to compare miRNA profiles of CD4+ T cells from SPMS patients to healthy controls (HC) using whole miRNA transcriptome next-generation sequencing (NGS). Total RNA was extracted from CD4+ T cells and miRNA expression patterns analyzed using Illumina-based small-RNA NGS in 12 SPMS and 12 HC samples. Results were validated in a further cohort of 12 SPMS and 10 HC by reverse transcription quantitative polymerase chain reaction (RT-qPCR). RESULTS: The ten most dysregulated miRNAs identified by NGS were selected for qPCR confirmation; five (miR-21-5p, miR-26b-5p, miR-29b-3p, miR-142-3p, and miR-155-5p) were confirmed to be down-regulated in SPMS (p < 0.05). SOCS6 is targeted by eight of these ten miRNAs. Consistent with this, SOCS6 expression is up-regulated in SPMS CD4+ T cells (p < 0.05). This is of particular interest as SOCS6 has previously been shown to act as a negative regulator of T cell activation. CONCLUSIONS: Ninety-seven percent of miRNA candidates identified by NGS were down-regulated in SPMS. The down-regulation of miRNAs and increased expression of SOCS6 in SPMS CD4+ T cells may contribute to reduced immune system activity in progressive MS.
Citation Information
Katherine A Sanders, Miles C Benton, Rod A Lea, Vicki E Maltby, et al.. "Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells." Clinical Epigenetics Vol. 8 Iss. 1 (2016) p. 87 - 87 ISSN: 1868-7083
Available at: http://works.bepress.com/lotti_tajouri/38/